Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/18/1996 | CN1131148A Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas |
09/18/1996 | CN1131144A Glycinamide derivatives, processes for their preparation and medicines containing them |
09/18/1996 | CN1131041A Soft gelatin pharmaceutical dosage form |
09/18/1996 | CN1131023A Plaster for curing hyperosteogeny |
09/18/1996 | CN1131020A Medicine for reducing blood sugar and its preparation method and use |
09/18/1996 | CN1131017A Zengshengling oil and preparing method thereof |
09/18/1996 | CN1032815C Method for preparation of selective adenosine receptor agents |
09/18/1996 | CN1032787C Synergistic treatment method |
09/18/1996 | CA2171695A1 Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation |
09/18/1996 | CA2144885A1 Enriched vinegar product and method of making the same |
09/17/1996 | US5557006 1-Alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds |
09/17/1996 | US5556993 Psoralen compounds for deactivation of hepatitis and hivviruses |
09/17/1996 | US5556990 Squalene synthase inhibitors, anticholesterol agents |
09/17/1996 | US5556983 Phenylimidazolidines |
09/17/1996 | US5556981 Angiotensin II antagonist intermediates |
09/17/1996 | US5556979 7-isoindolinyl-naphthyridone derivatives, compositions and anti-bacterial use thereof |
09/17/1996 | US5556977 Antiagglomerants for cells, anticoagulants, antiischemic agents using pyridinylpiperazine derivatives |
09/17/1996 | US5556973 Red-shifted tris-aryl-s-triazines and compositions stabilized therewith |
09/17/1996 | US5556970 Lanolin fatty acids, a method for their fractionation, cosmetics and drugs for external use |
09/17/1996 | US5556968 Polyazamacrocycle chelating agents with amide linkages |
09/17/1996 | US5556965 Chemical intermediates for steroids |
09/17/1996 | US5556909 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof |
09/17/1996 | US5556886 HIV-inhibiting benzeneacetamide derivatives |
09/17/1996 | US5556882 Methods of treating wrinkles using benzilic acid |
09/17/1996 | US5556878 Δ6,7 -taxols antineoplatic use and pharmaceutical compositions containing them |
09/17/1996 | US5556877 Antitumor agents |
09/17/1996 | US5556876 Anticholesterol agents using derivatives of benzothienyl ketones |
09/17/1996 | US5556875 1,2-dithiin antiinfective agents |
09/17/1996 | US5556872 Histamine derivatives useful as immunomodulators |
09/17/1996 | US5556871 Method for treating epithelial precancerous lesions with topical inidazoles |
09/17/1996 | US5556870 Use of leflunomide for inhibiting interleukin 1 beta |
09/17/1996 | US5556868 Antiparasitic avermectin and milbemycin derivatives |
09/17/1996 | US5556866 Hair restorer and its preparation |
09/17/1996 | US5556864 Treatment of circulatory diseases and psychosis |
09/17/1996 | US5556863 Antiinflammatory agents and antisecretory agents for gastric juice |
09/17/1996 | US5556862 Pharmaceutical compositions containing isoquinoline derivatives |
09/17/1996 | US5556860 Quinazolinone derivatives possessing calcium uptake inhibiting activity |
09/17/1996 | US5556858 Cis-2-[(4-heteroaryl-1-piperazinyl)alkyl] hexahydro-1H-isoindole-1,3 (2H)-diones and related compounds and their therapeutic utility |
09/17/1996 | US5556857 Disturbance-of-consciousness improving agent |
09/17/1996 | US5556856 Anitarrhythmia, analgesics |
09/17/1996 | US5556855 N-heterocyclic substituted salicylic acids |
09/17/1996 | US5556854 Cardiovascular disorders and/or neurogenerative disorders |
09/17/1996 | US5556853 Epoxysuccinic acid derivatives |
09/17/1996 | US5556851 Treatment of nausea or emesis from anticancer drugs or x-ray treatment |
09/17/1996 | US5556850 Bactericides |
09/17/1996 | US5556849 Ruthenium containing phthalocyanin photosensitizers |
09/17/1996 | US5556848 Antiinflammatory agents and antiallergens |
09/17/1996 | US5556847 Sulfamic acid-substituted |
09/17/1996 | US5556846 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, and pharmaceutical compositions containing same |
09/17/1996 | US5556845 11-β substituted-19-nor steroids |
09/17/1996 | US5556844 Synergistic, skin disorders |
09/17/1996 | US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c |
09/17/1996 | US5556840 2',5'-phosphorothioate oligoadenylates as anitiviral agents |
09/17/1996 | US5556838 Blocking n-methylaspartate receptors to prevent addiction |
09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
09/17/1996 | US5556754 Major histocompatibility complex, treatment of autoimmune diseases |
09/17/1996 | US5556645 Methods of enhancing wound healing and tissue repair |
09/17/1996 | US5556644 Nutritional supplement for the elderly |
09/17/1996 | US5556639 Lamotrigine anticonvulsant |
09/17/1996 | US5556638 Flurbiprofen-containing immediate-effect medicament and its use |
09/17/1996 | US5556619 Bile acid sequesterants to lower blood cholesterol, polyamines |
09/17/1996 | US5556614 Deodorant composition |
09/17/1996 | US5556612 Methods for phototherapeutic treatment of proliferative skin diseases |
09/17/1996 | US5556611 Preventing and treating mucosal diseases of epithelia of tracheobronchial tract by topically applying aerosol inhalate comprising ester of retinoic acid or ester of retinol; particles of specified size |
09/17/1996 | CA2086763C Sewing machine needle and method for manufacturing same |
09/17/1996 | CA2047027C Tablet and granulate containing mesna as active substance |
09/17/1996 | CA2021894C Antiparasitic agent |
09/17/1996 | CA2019466C Minerals in bioavailable form |
09/17/1996 | CA2004249C Arylpiperidine derivatives |
09/17/1996 | CA1338599C Imidazole derivatives |
09/16/1996 | CA2171509A1 Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment |
09/14/1996 | CA2171579A1 Piperidine derivatives, process for the preparation thereof and application thereof in therapeutics |
09/12/1996 | WO1996027797A2 Zap 70 inhibitors and methods for treatment of zap 70 signal transduction disorders |
09/12/1996 | WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
09/12/1996 | WO1996027663A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
09/12/1996 | WO1996027658A1 Stimulation of meiosis |
09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
09/12/1996 | WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
09/12/1996 | WO1996027601A1 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives |
09/12/1996 | WO1996027594A1 Antitumour isocoumarins |
09/12/1996 | WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity |
09/12/1996 | WO1996027588A1 Indole derivatives as eaa antagonists |
09/12/1996 | WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives |
09/12/1996 | WO1996027391A1 Drug for treating immunity-related diseases and method of searching for the same |
09/12/1996 | WO1996027390A1 Compositions and methods for stimulating antibody class switching |
09/12/1996 | WO1996027384A2 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase |
09/12/1996 | WO1996027383A1 Compositions having antiviral properties and preparation process |
09/12/1996 | WO1996027380A1 Reduction of infarct volume using citicoline |
09/12/1996 | WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8 |
09/12/1996 | WO1996027377A1 Methods and compositions for sedating, anaesthetising and euthanising aquatic organisms |
09/12/1996 | WO1996027376A1 Corticosteroid-containing pharmaceutical composition |
09/12/1996 | WO1996027375A2 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
09/12/1996 | WO1996027374A1 Treatment of cytokine growth factor caused disorders |
09/12/1996 | WO1996027373A1 Use of n-substituted l-phenylalanine esters for the treatment of eczema |
09/12/1996 | WO1996027372A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
09/12/1996 | WO1996027371A1 Product against deficiency |
09/12/1996 | WO1996027370A1 Free radical scavenger molecules |
09/12/1996 | WO1996027369A2 Compositions for the treatment of blood disorders |
09/12/1996 | WO1996027368A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
09/12/1996 | WO1996027365A1 Gentle anti-acne composition |